Skip to content

Adaptive resistance exercise equipment

The strength dose-response in 28 minutes a week. Peer-reviewed.

ARX Alpha and Omni are specified by clinicians, business operators, private buyers, and the architects, designers and builders who place them in their clients' homes.

Find your path

Five buyer profiles route to a page tailored to that profile's clinical or commercial framing. A sixth path serves the design-channel professionals who specify ARX into a client's project rather than buy for themselves.

Medical Professional

Longevity, regenerative, weight-loss, hormone, integrated-medical, sports-PT and chiropractic clinics integrating adaptive resistance into clinical protocols.

Business Operator

Boutique studios, corporate wellness programs, athletic facilities and independent strength coaches running ARX as a revenue-generating service line.

Private Buyer

Private buyers integrating ARX into a home longevity, performance or recovery routine — biohackers, executives and active or retired professional athletes.

Senior Living Operator

Luxury CCRC and senior-living wellness centers using ARX for fall-prevention, sarcopenia and clinical strength programs.

Clínica en México

Stem-cell, longevity and regenerative clinics serving medical-tourism patients in Mexico. LFPDPPP-compliant capture; Spanish protocol training included.

Architects, designers, builders, integrators

Spec ARX into a client project. Co-pitch resources, footprint + finish specs, trade economics and a direct line to the ARX specifier desk.

Why operators integrate ARX

Two 15-minute sessions per week reach the strength dose-response threshold required for clinical outcomes. Equivalent gains, fewer hours of clinician or coach attention per patient or member.

Underlying clinical evidence

  • Dalleck 2021 RCT: Equivalent strength gains in less than half the time-on-machine vs. conventional resistance training.(verification pending)
  • AEL meta-analysis: Accentuated-eccentric loading drives greater hypertrophy and strength adaptation per session than concentric-only protocols.(verification pending)
  • GLP-1 muscle-loss cohort: Adaptive resistance preserves lean mass during GLP-1 weight loss when other modalities can't reach the dose-response threshold.(verification pending)
  • Time-efficiency studies: Two 15-minute sessions per week reach the strength dose-response threshold required for clinical outcomes.(verification pending)
  • Nuzzo 2023 CARE framework: The eccentric phase of adaptive resistance is mechanistically distinct from concentric-only loading; the dose-response advantage compounds across joint integrity, hypertrophy and strength.(verification pending)
  • Once-Weekly Eccentric protocol: Once-weekly eccentric protocols reach the dose-response threshold that conventional 3x/week routines target — the time-efficiency story for HNW and busy clinical buyers.(verification pending)
  • Oldest-old strength outcomes: Adaptive resistance produces meaningful strength and balance gains in the 80+ cohort where fall-prevention ROI is most measurable on incident rates and downstream care costs.(verification pending)
  • JAMA Network Open GLP-1 muscle loss: Patients on semaglutide / tirzepatide retain lean mass at meaningfully lower rates than non-GLP-1 weight-loss cohorts; structured resistance is the documented mitigation.(verification pending)
  • Galiano 2024 sarcopenia review: Resistance-based intervention slows sarcopenia progression in HRT-cohort patients; bone density outcomes correlate with adherence to dose-response strength protocols.(verification pending)
  • Delphi Consensus — longevity protocols: Expert consensus on the role of dose-response resistance training in longevity protocols — the strength dose is the consensus floor under which other longevity interventions underperform.(verification pending)
  • Resistance training & mortality: Sustained resistance training is independently associated with reduced all-cause mortality; the time-efficient delivery model preserves the effect at lower compliance burden.(verification pending)
  • Mayo clinical adoption white paper: Clinical adoption framework documents reimbursement-pathway and operator-economics models for adaptive resistance integration in integrated medical practice.(verification pending)

Three ways to evaluate ARX

Schedule a paid demo

In-person or virtual. 15-minute hands-on session. Refunded against the first machine purchase.

Run the ROI calculator

Model revenue per square foot, member economics and payback at your facility size and pricing.

Read the clinical evidence

Peer-reviewed studies, force-curve methodology and protocol templates by clinical use case.